The presently described system relates generally to the advancement of medical technology, processes, and systems for the treatment of pain, neurological disorders, and other clinical maladies related to neural dysfunction. More specifically, the present disclosure is directed at a system for producing therapeutic lesions or tissue alterations by means of a high frequency generator connected to a patient via more than one electrode. In below-described exemplary embodiments, therapeutic energy is delivered and regulated simultaneously. Various specific exemplary embodiments of this device accommodate specific exemplary clinical applications and designs.
The general use of radiofrequency and high frequency generator systems which deliver electrical output to electrodes that are connected to a patient's body is known in the clinical literature and art.
By reference, an example of radiofrequency heat lesioning generators used in clinical practice for the treatment of neural disorders is the Radionics RFG-3C+ (Burlington Mass).
This device is capable of delivering high frequency energy to patient tissue via an adapted electrode, and associated ground or reference electrode. This device is also capable of delivering low frequency stimulation pulses that are used to accurately localize the electrode placement before treatment.
Parameters that may be measured by these devices include impedance, HF voltage, HF current, HF power, and electrode tip temperature. Parameters that may be set by the user include time of energy delivery, desired electrode temperature, stimulation frequencies and durations, and level of stimulation output. In general, electrode temperature is a parameter that may be controlled by the regulation of high frequency output power.
These devices have various user interfaces that allow the selection of one or more of these treatment parameters, as well as various methods to display the parameters mentioned above.
In one application of these devices, a patient complains of back pain, or some other pain of nocioceptive or neuropathic origin. A doctor then performs diagnostic blocks with local anesthetic by injecting the anesthetic into the areas that is suspected of generating the pain. If the patient receives temporary relief from these injections the doctor concludes that the pain generators were in the location where he made these injections. Unfortunately, the origin of pain is poorly understood; perceived pain at a certain level in the back, for instance, can actually be created from many different and multiple sources.
Once a location has been identified, the clinician will decide to deliver high frequency energy to this location to permanently destroy the pain generator. A ground or reference plate will be placed on the patient's thigh to provide a return path for the high frequency energy. An insulated electrode with a small un-insulated tip will be placed at the expected target. Stimulation pulses will be delivered at a sensory frequency (typically 50 Hz), and a stimulation voltage will be placed on the electrode. The clinician is looking for a very low threshold of response from the patient (e.g., less than 0.5 V) to ensure that the electrode is close to the sensory nerves. They will then perform a stimulation test at a muscle motor frequency (e.g., 2 Hz), and increase the stimulation voltage output to 2 v. In this instance, they are looking for no motor response in the patient's extremities as this would indicate the electrode was too close to the motor nerves. Treatment in this area could cause paralysis. Upon successful completion of these tests, high frequency energy is typically delivered for one or more minutes, while maintaining an electrode tip temperature between 70 and 90 degrees. Alternatively, high frequency energy may be delivered for one or more minutes, but in a pulsed mode where the high frequency energy is on for a short period of time and off for a long period of time, thus not producing any appreciable heating (reference is made to commonly assigned U.S. Pat. No. 6,161,048, the entire contents of which are specifically incorporated by reference herein).
Although these treatments are successful, they have several drawbacks. In practice, most patients need treatments at several different nerve locations. This requires placing the electrode, performing the stimulation, and delivering the energy at each location and then repeating the process, thus causing a great deal of wasted time, and patient discomfort, while waiting for the energy to be delivered. Another drawback is that in spite of successful stimulation testing, the target nerve is often not destroyed resulting in no decrease of pain. The clinician is left to determine whether the target nerve has been missed, or whether the pain generator is located else where in the body.
The above-described and other disadvantages of the art are overcome and alleviated by the present method and system for taking the energy output from a high frequency generator module and delivering this energy simultaneously to more than one treatment electrode. In one exemplary embodiment, the energy is regulated by a feedback mechanism such that each electrode's tip temperature is maintained to a level set by the user. This greatly reduces treatment time, providing the patient with a shorter period of discomfort as well as not wasting valuable procedure room time.
In additional exemplary embodiments, EMG measurements are displayed to allow the clinician to determine whether the target nerve has been destroyed, as well as the display of pre-treatment and post-treatment sensory stimulation thresholds to measure the degree of desensitation of the target nerve. Regarding the EMG measurements, this allows the clinician to determine whether the target nerve has been successfully treated; if it has been, then other pain generation sources need to be investigated. The capability of being able to compare pre-treatment and post-treatment sensory stimulation thresholds gives the clinician an immediate look at the immediate desensitation of the target nerve.
In accordance with one exemplary embodiment, the device receives input from a module capable of delivering both high frequency energy as well as low frequency stimulation pulses, such as between 1 and 100 Hz. The device is, in turn, connected to greater than one treatment electrode. These electrodes have temperature sensors attached to their tips, which reports the tip temperature of each electrode to the device. The device has a user interface which allows the output from the said module to be independently connected to each said electrode and also a means which connects all the electrodes simultaneously to the output of the said module. In this way, the low frequency stimulation output can be independently connected to each of the patient electrodes, and then the said electrodes can be connected simultaneously to the high frequency power source, thus permitting temperature regulation of the three electrodes simultaneously. This allows both sensory and motor stimulation testing, as well as impedance monitoring to be performed on each electrode one at a time. When the therapeutic energy is desired to be delivered, the user interface allows a means which connects all electrodes together simultaneously. The device then receives the tip temperature from each of the multiple electrodes, as well as a set temperature for each electrode that is chosen by the user. The device continually compares each of the temperatures from the electrodes to the set temperature. If the electrode tip temperature ever exceeds the set temperature, the high frequency energy is disconnected from that electrode. Similarly, if the electrode tip temperature is ever less than the set temperature, the high frequency energy is either left connected or reconnected to that electrode.
Another exemplary embodiment of this invention incorporates a graphic display, which allows EMG signals to be recorded to and displayed. An additional provision allows for a speaker and/or a headphone output so that the EMG signals can also be audibly detected and analyzed.
It should be noted that the present system and method can be incorporated into high frequency power source, or can be a stand-alone peripheral device that connects in-between the high frequency power source and the electrodes.
For at least the reasons described above, this method and invention provides practical and clinical advantages in the treatment of pain. Additional advantages will become apparent in the detailed descriptions that follow.
The above discussed and other features and advantages of the present system will be appreciated and understood by those skilled in the art from the following detailed description and drawings.
Referring now to the figures, which are exemplary embodiments and wherein the like elements are numbered alike:
Referring to
It is very important to note two things from this figure—one is that to the high frequency power source that delivers the high frequency energy and/or low frequency stimulation pulses could be incorporated into this device or could be a separate stand-alone unit, with this device interposed between the high frequency power source and the electrodes. Though the figure shows this device as being AC line connected (that is requiring an electrical outlet for the unit to be plugged into), a battery-operated device may also be used.
It should also be understood that mode selection could be done in many ways and the features of this user interface could be achieved with or without displays, and could use up/down pushbuttons rather than rotatable selector knobs. For instance, mode select could individually connect each electrode to the high frequency device, and could also have a position which independently connected each electrode to any EMG measuring circuit, where the EMG signal was then displayed on a two-dimensional graphics display. An additional position on the mode select would be high frequency energy delivery where either continuous or pulsed high frequency energy was delivered simultaneously to each electrode and a feedback circuit was incorporated to maintain each electrode tip at a temperature equal to set temp.
It should also be noted there are many ergonomic manifestations of this invention and it would be possible to add additional displays, buttons, and/or indicators to allow and/or assist the operator in controlling the device. For instance,
10B in the figure represents Electrode 2. As can be seen by 11B, and 12B, a temperature sensor is incorporated into the electrode that reports the temperature at the electrode tip, as well as a means for applying the high frequency energy to the electrode. Temperature is reported via 21B to Control 2, identified by 30B in the figure. Control 2 also has an input identified as set temperature 20B, and compares these two signals to determine whether to open or close switch S2 (identified by 50B). It is important to note that S2 is a generic switch and can be achieved both electrically and/or mechanically and/or optically. The High Frequency energy in, represented by 40B in the figure, is therefore connected and disconnected to Electrode 2 via switch S2. As switch S2 is opening and closing via Control 2, (which is constantly comparing the user set temperature to the reported electrode tip temperature and determining whether to deliver HF energy to Electrode 2), a feedback circuit is established which will maintain the Electrode 2 temperature at the user set temperature.
In
In
While the disclosure has been described with reference to exemplary embodiments, it will be understood by those skilled in the art that various changes may be made and equivalents may be substituted for elements thereof without departing from the scope of the disclosure. In addition, many modifications may be made to adapt a particular situation or material to the teachings of the disclosure without departing from the essential scope thereof. Therefore, it is intended that the disclosure not be limited to the particular embodiment disclosed as the best mode contemplated for carrying out this disclosure, but that the disclosure will include all embodiments falling within the scope of the appended claims.
This application is a continuation of U.S. patent application Ser. No. 11/498,446 filed on Aug. 2, 2006, entitled “Method and Apparatus for Diagnosis and Treating Neural Dysfunction”, which issued as U.S. Pat. No. 7,574,257 on Aug. 11, 2009, and which claims priority to U.S. Provisional Patent Application No. 60/704,849, filed on Aug. 2, 2005, the entire disclosures of which are hereby incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
3898991 | Ikuno et al. | Aug 1975 | A |
4907589 | Cosman | Mar 1990 | A |
5233515 | Cosman | Aug 1993 | A |
5370672 | Fowler et al. | Dec 1994 | A |
5433739 | Sluijter et al. | Jul 1995 | A |
5456682 | Edwards et al. | Oct 1995 | A |
5474558 | Neubardt | Dec 1995 | A |
5678568 | Uchikubo et al. | Oct 1997 | A |
5718701 | Shai et al. | Feb 1998 | A |
5782826 | Swanson | Jul 1998 | A |
5820568 | Willis | Oct 1998 | A |
5837001 | Mackey | Nov 1998 | A |
5868666 | Okada et al. | Feb 1999 | A |
5868737 | Taylor et al. | Feb 1999 | A |
5871481 | Kannenberg et al. | Feb 1999 | A |
5951546 | Lorentzen | Sep 1999 | A |
5983141 | Sluijter et al. | Nov 1999 | A |
6006129 | Watson | Dec 1999 | A |
6014581 | Whayne et al. | Jan 2000 | A |
6056745 | Panescu et al. | May 2000 | A |
6074213 | Hon | Jun 2000 | A |
6117127 | Helmreich et al. | Sep 2000 | A |
6123702 | Swanson et al. | Sep 2000 | A |
6161048 | Sluijter et al. | Dec 2000 | A |
6212426 | Swanson | Apr 2001 | B1 |
6231569 | Bek et al. | May 2001 | B1 |
6246912 | Sluijter et al. | Jun 2001 | B1 |
6251113 | Appelbaum et al. | Jun 2001 | B1 |
6259952 | Sluijter et al. | Jul 2001 | B1 |
6312426 | Goldberg et al. | Nov 2001 | B1 |
6409722 | Hoey et al. | Jun 2002 | B1 |
6416520 | Kynast et al. | Jul 2002 | B1 |
6440127 | McGovern et al. | Aug 2002 | B2 |
6447505 | McGovern et al. | Sep 2002 | B2 |
6451015 | Rittman, III et al. | Sep 2002 | B1 |
6478793 | Cosman et al. | Nov 2002 | B1 |
6506189 | Rittman, III et al. | Jan 2003 | B1 |
6517534 | McGovern et al. | Feb 2003 | B1 |
6530922 | Cosman et al. | Mar 2003 | B2 |
6565511 | Panescu et al. | May 2003 | B2 |
6572551 | Smith et al. | Jun 2003 | B1 |
6575969 | Rittman, III et al. | Jun 2003 | B1 |
6692493 | McGovern et al. | Feb 2004 | B2 |
6881214 | Cosman et al. | Apr 2005 | B2 |
6918771 | Arington et al. | Jul 2005 | B2 |
7169143 | Eggers et al. | Jan 2007 | B2 |
7270659 | Ricart et al. | Sep 2007 | B2 |
7282049 | Orszulak et al. | Oct 2007 | B2 |
7331956 | Hovda et al. | Feb 2008 | B2 |
7344533 | Pearson et al. | Mar 2008 | B2 |
7574257 | Rittman, III | Aug 2009 | B2 |
20030032951 | Rittman et al. | Feb 2003 | A1 |
20050113703 | Farringdon et al. | May 2005 | A1 |
20050113730 | Runeman et al. | May 2005 | A1 |
20050277918 | Shah et al. | Dec 2005 | A1 |
20060085054 | Zikorus et al. | Apr 2006 | A1 |
20060095103 | Eggers et al. | May 2006 | A1 |
20060282139 | Weintraub | Dec 2006 | A1 |
20060289528 | Chiu et al. | Dec 2006 | A1 |
20070043405 | Rittman, III | Feb 2007 | A1 |
20070100278 | Frei et al. | May 2007 | A1 |
20070118109 | Baker et al. | May 2007 | A1 |
20070142873 | Esteller et al. | Jun 2007 | A1 |
20070142875 | Shalev et al. | Jun 2007 | A1 |
20070250119 | Tyler et al. | Oct 2007 | A1 |
20080004615 | Woloszko et al. | Jan 2008 | A1 |
20080009847 | Ricart et al. | Jan 2008 | A1 |
20080046012 | Covalin et al. | Feb 2008 | A1 |
20080287944 | Pearson et al. | Nov 2008 | A1 |
Number | Date | Country |
---|---|---|
1493397 | Jan 2005 | EP |
WO 8501213 | Mar 1985 | WO |
WO 9400188 | Jan 1994 | WO |
WO 9713550 | Apr 1997 | WO |
WO 9749453 | Dec 1997 | WO |
WO 0112089 | Feb 2001 | WO |
WO 2004067085 | Aug 2004 | WO |
WO 2006092021 | Sep 2006 | WO |
WO 2006099462 | Sep 2006 | WO |
WO 2006119467 | Nov 2006 | WO |
WO 2006134598 | Dec 2006 | WO |
Number | Date | Country | |
---|---|---|---|
20100016926 A1 | Jan 2010 | US |
Number | Date | Country | |
---|---|---|---|
60704849 | Aug 2005 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11498446 | Aug 2006 | US |
Child | 12501074 | US |